Shockwave therapy is a non-invasive treatment that uses controlled acoustic energy to stimulate tissue repair, reduce chronic pain, and support recovery across a wide range of musculoskeletal conditions. For clinics across Canada, it’s becoming an increasingly valuable tool – both for improving patient outcomes and for expanding what can be treated effectively within everyday practice.
If you’re exploring what is shockwave therapy and whether it makes sense to integrate into your clinic, this guide walks through the essentials. We’ll look at how shockwave therapy works, where the clinical evidence is strongest, and what Canadian practitioners should consider when evaluating the right system for their patients and workflow.
In short, shockwave therapy is a non-invasive treatment that uses acoustic waves to stimulate healing in injured tissues. It’s a familiar part of many Canadian MSK clinics, but there’s still some confusion about what it actually does and where it fits in treatment planning. Understanding the basics helps clarify why it’s become such a reliable option for chronic tendon and soft-tissue conditions.
Shockwave therapy delivers rapid pulses of acoustic energy through the skin into targeted tissue, where it triggers a series of biological responses associated with repair. These signals increase local blood flow, support the formation of new blood vessels, and stimulate collagen production within damaged structures. Treatment also reduces levels of Substance P, a neurotransmitter linked to persistent pain. In practical terms, this helps explain how shockwave therapy works beyond short-term symptom relief. It encourages healing in tissue that has stalled in a chronic state, which is why it’s commonly used for conditions that haven’t responded to rest, medication, or conventional rehabilitation alone.
There are two primary types of shockwave therapy used in clinical practice: radial and focused.
Radial shockwave therapy distributes energy outward from the applicator tip across a broader treatment area, making it especially well suited to the tendon and soft-tissue conditions most commonly seen in physiotherapy, chiropractic, and sports medicine clinics – including plantar fasciitis, Achilles and patellar tendinopathy, lateral epicondylitis, and myofascial pain.
Focused shockwave therapy concentrates energy at a deeper, more precise point within tissue and is typically used for more localized or deeper targets. For the majority of Canadian clinics treating everyday musculoskeletal presentations, radial shockwave therapy represents the most practical and widely adopted approach, with strong clinical evidence supporting outcomes across a large range of routine indications.
Across Canada, more patients are actively looking for non-invasive, drug-free options that help them recover faster and avoid injections or surgery where possible. Shockwave therapy fits naturally into that shift. It gives clinicians a way to address stubborn tendon and soft-tissue conditions that often plateau with exercise-based rehab alone, while supporting measurable progress over a defined course of treatment. Radial ESWT, in particular, aligns well with the conditions most clinics see every day, making it both a practical clinical upgrade and a strong addition to service offerings. For many physiotherapy, chiropractic, and sports medicine practices, it has become a reliable way to improve outcomes while creating a consistent new treatment revenue stream and strengthening their competitive position locally.
For clinics considering how shockwave therapy fits into everyday practice, it helps to look at both the strongest evidence base and the ways its use continues to expand. These sections highlight where outcomes are most consistent and how the modality supports modern treatment workflows.
For clinicians considering where shockwave therapy makes the biggest impact, the strongest evidence sits around a core group of tendon conditions seen every day in practice. Plantar fasciitis, Achilles and patellar tendinopathy, lateral epicondylitis, and calcific rotator cuff tendinopathy all show consistent improvements in pain and function across clinical trials, with outcomes that hold up at follow-up. These are also some of the most common presentations in Canadian physiotherapy and chiropractic clinics, which means shockwave therapy can begin supporting patient care almost immediately after it’s introduced into a treatment workflow.
Beyond tendon conditions, shockwave therapy is increasingly being explored across a wider range of musculoskeletal presentations. Emerging research supports its use for myofascial trigger points, chronic low back pain, knee osteoarthritis, and carpal tunnel syndrome, with additional interest in areas like primary dysmenorrhea. While these applications continue to develop, many clinics are already incorporating shockwave therapy into care plans where conventional approaches alone haven’t produced the progress expected. Used thoughtfully and within evidence-informed parameters, these expanding indications give clinics more flexibility in how they support complex or persistent patient presentations.
Shockwave therapy works best when it’s integrated into a broader rehabilitation strategy rather than used as a single, standalone treatment. In physiotherapy and chiropractic settings, it often complements manual therapy, progressive loading programs, and patient education by helping address tissue that has stalled in a chronic healing state. This allows the rest of the treatment plan to build strength, mobility, and confidence more effectively around it. In everyday practice, shockwave therapy becomes less about replacing existing approaches and more about strengthening them, giving clinicians another option when progress has slowed or symptoms have persisted longer than expected.
Explain that shockwave therapy devices used in Canada are regulated by Health Canada and must meet specific safety and classification standards. Highlight that this regulatory oversight ensures patient safety, device quality, and consistent clinical standards. Position this as a key differentiator that strengthens trust and demonstrates adherence to national healthcare regulations.
Shockwave therapy devices used in Canada fall within Health Canada’s medical device regulatory framework and must meet defined safety and licensing requirements before they can be used in clinical practice. For clinic owners evaluating what shockwave therapy equipment to bring into their setting, confirming that a device holds proper authorization is an essential first step. This process ensures the technology delivers energy safely and consistently according to recognized standards. It also protects both patients and practitioners by reducing legal and operational risk. In practical terms, choosing a licensed shockwave therapy system helps ensure the treatment you’re offering reflects the same level of clinical reliability expected across regulated Canadian healthcare environments.
Shockwave therapy in Canada is typically delivered by regulated healthcare professionals such as physiotherapists, chiropractors, sports medicine physicians, and rehabilitation practitioners. Because scope of practice varies slightly between provinces, clinicians should confirm that shockwave therapy fits within their regulatory guidelines before introducing it into patient care. Beyond scope considerations, safe implementation depends on understanding how shockwave therapy works, including treatment timing, contraindications, and appropriate patient selection. With the right clinical training in place, shockwave therapy becomes a predictable and effective addition to musculoskeletal treatment plans.
Using properly authorized shockwave therapy equipment supports both patient safety and long-term clinic credibility. Devices that meet Health Canada requirements are designed to deliver consistent therapeutic energy levels, which directly affects treatment quality and reliability. For clinic owners researching what is shockwave therapy from both a clinical and operational perspective, compliance is part of making sure the service performs as expected over time. It also helps protect professional reputation and reduces unnecessary liability risk. In everyday practice, choosing regulated shockwave therapy systems and following established protocols simply reflects the same standards clinics already apply to other evidence-based treatment technologies.
Adding shockwave therapy to your clinic is a significant decision, and one that deserves a straightforward conversation rather than a form submission into the void. Whether you’re ready to move forward or still weighing your options, Shockwave Canada’s team is available to walk you through device options, leasing and purchase pricing, training, and what integration into your practice actually looks like. Reach out to speak with an expert, request a consultation, or get a quote – and take the first step toward offering one of the most in-demand, evidence-supported treatments in Canadian clinical practice today.
Contact Sales for more information.
Yes. Shockwave therapy is supported by a substantial body of peer-reviewed clinical research across a range of musculoskeletal conditions. Studies consistently report meaningful improvements in pain, function, and tissue healing, particularly in chronic conditions that have not responded to other conservative treatments. Like any clinical intervention, outcomes depend on the condition being treated, the quality of the device, and the expertise of the practitioner delivering treatment. When these factors are aligned, the evidence for shockwave therapy is strong.
Reported improvement rates vary by condition, but clinical evidence suggests success rates ranging from 77% to 91% across common indications including plantar fasciitis, calcific tendinopathy, and Achilles tendinopathy – figures drawn from studies conducted using STORZ Medical devices. It is worth noting that these outcomes are tied to specific devices and protocols. Clinics using properly engineered equipment and evidence-based treatment parameters are best positioned to replicate these results in practice.
Yes. Shockwave therapy devices used in Canadian clinical settings fall under Health Canada’s medical device regulatory framework and must meet specific classification and safety standards before they can be legally marketed or used. Clinics should verify that any device they purchase or lease holds the appropriate Health Canada authorization. Shockwave Canada supplies devices that meet Canadian regulatory requirements, ensuring clinics remain compliant and patients remain protected.
Shockwave therapy is one of the higher-margin modalities a Canadian clinic can offer. Sessions are short, require no consumables, and generate consistent per-session revenue with low operational overhead. At an average of $100 per session, a single patient per month covers the monthly leasing cost of a device – making the return on investment straightforward to calculate and relatively quick to realize once the service is established in a clinic’s offering.
Clinical studies consistently show that shockwave therapy produces durable outcomes that hold up at follow-up assessments conducted months after treatment concludes. Unlike interventions that provide temporary symptomatic relief, shockwave therapy works by stimulating genuine tissue repair, which means improvements tend to be maintained rather than reversed once the healing process completes. Individual results vary depending on the condition, its severity, and the patient’s overall health, but the evidence supports shockwave therapy as a treatment with lasting effect rather than a short-term fix.